Company news

Essilorluxottica Sa (EURONEXT:EL) news

Every Essilorluxottica Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Essilorluxottica Sa stock analysis →

Press releases & updates

EssilorLuxottica : 24-Month U.S. Clinical Trial Results Supporting FDA De Novo Market Authorization of Essilor Stellest Lenses* Published...

August 27, 2026

EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation

July 16, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026

July 7, 2026

Malaysia Faces Rising Childhood Myopia Challenge: VISTA Eye Specialist, EssilorLuxottica, UiTM and SK Jalan U3 Join Forces to Protect Chi...

July 3, 2026

LensCrafters Enters a New Era of Med-Tech Innovation, Building an Integrated Ecosystem of Care

June 30, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026

June 9, 2026

EssilorLuxottica : to start wearable production in Italy

June 9, 2026

EssilorLuxottica : Result of the payment of dividends in shares and record of the corresponding capital increase

June 1, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026

May 12, 2026

EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting

April 28, 2026

EssilorLuxottica: Disclosure of transactions in own shares

April 27, 2026

EssilorLuxottica : acquires the Italian company Faro, advancing high-precision technologies in eyewear manufacturing

April 23, 2026

EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth

April 22, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026

April 10, 2026

EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand

April 2, 2026

EssilorLuxottica and Meta Expand AI Glasses Portfolio with Ray-Ban Meta Optics Styles

March 31, 2026

EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050

March 16, 2026

EssilorLuxottica's Inaugural SWITCH: Vision Innovation Summit delivers an inspiring deep dive into the future of vision care and healthca...

March 12, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026

March 12, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026

March 10, 2026

EssilorLuxottica: 2025 Universal Registration Document filed

March 6, 2026

AM Best Affirms Credit Ratings of EyeMed Insurance Company

February 19, 2026

EssilorLuxottica announces the launch of a share buyback program

February 13, 2026

EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors

February 11, 2026

EssilorLuxottica: Q4/FY 2025 Results - Revenue growing 18.4% in Q4 and 11.2% in the FY. Adj. operating margin at 16.0% in the FY

February 11, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026

February 10, 2026

EssilorLuxottica: Full-Year 2025 Results Conference Call Invitation

February 2, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025

January 13, 2026

LensCrafters Continues Dedicated to Everyday Excellence Campaign in 2026 with Award‑Winning Optometrist Dr. Anisha Haji

January 5, 2026

EssilorLuxottica and Burberry announce licensing partnership renewal

December 18, 2025

EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint

December 12, 2025

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear

December 10, 2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025

December 9, 2025

EssilorLuxottica creates Scientific Advisory Committee to accelerate the next era of innovation

December 1, 2025

Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect memb...

November 14, 2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2025

November 12, 2025

EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solu...

November 6, 2025

EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group

October 16, 2025

EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions

October 15, 2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025

October 9, 2025

EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation

October 6, 2025

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States

September 25, 2025

EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future

September 17, 2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025

September 11, 2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2025

September 1, 2025

EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing

August 4, 2025

EssilorLuxottica: Q2/H1 2025 Results - Sound revenue growth at 7.3% in Q2 and H1, AI glasses speeding up further

July 28, 2025

EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials

July 21, 2025

EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation

July 17, 2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2025

July 9, 2025

Older →